Novan, Inc.
Novan, Inc. (NOVN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NOVN · as of Jun 9, 2026
Key Statistics
Explore Novan, Inc. Data
novn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
novn competitorsNOVN
AFMD
ARAV
BPTS
EIGRQ
MTPStock Performance
Full HistoryAbout Novan, Inc.
Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-sta…
what is novan, inc. · novn stock overview · novan, inc. company profile · who is novan, inc. ceo · novn NASDAQ · novan, inc. headquarters · novan, inc. business segments
About Stock Overview & Key Data
Novan, Inc. (NOVN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 21, 2016. As of the latest trading session, NOVN stock price is $0.09, with a market capitalization of $2.6M. The stock has returned -96.41% over the past 12 months and -94.33% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Novan, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Novan, Inc. reported revenue of $23.6M and net income of -$19.6M. For detailed data — including Novan, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novan, Inc. (NOVN) stock price is $0.09. The stock is traded on NASDAQ under the ticker symbol NOVN. The 52-week range is $0.08 – $3.33.